Insiders Personalis, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
1.36 ^USD	+7.51%		+7.94%	-35.24%

Mar. 26	Personalis, Inc. Announces Publication Validating Next Personal Test for Ultra-Sensitive MRD Detection and Cancer Treatment Response Monitoring	CI
Feb. 29	Needham Raises Price Target on Personalis to $3.50 From $2.30, Maintains Buy Rating	MT

Personalis, Inc. Appoints Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance	23-10-19	CI
Personalis, Inc. Announces Board Changes	23-06-13	CI
Personalis Appoints Christopher Hall Chief Executive Officer, Aaron Tachibana Chief Operating Officer	23-03-03	MT
Personalis, Inc. Announces Executive Changes	23-03-02	CI
Personalis, Inc. Appoints Christopher Hall as Chief Executive Officer	23-03-02	CI
Personalis CFO Aaron Tachibana Named Interim CEO After Incumbent Announces Plan to Retire	22-12-14	MT
Personalis, Inc. Announces Retirement of John West from the Board of Directors	22-12-14	CI
Personalis, Inc. Announces Retirement of John West as CEO	22-12-14	CI
Personalis, Inc. Appoints Christopher Hall as SVP and Head, Diagnostics Business	22-10-31	CI
Personalis, Inc. Appoints Lonnie Shoff to Its Board of Directors	22-08-03	CI
Personalis, Inc. Announces Board Changes	22-03-24	CI
Insider Sell: Personalis	22-01-20	MT
Insider Sell: Personalis	21-12-20	MT
Personalis Named to Inc.'s 2021 Best-Led Companies List	21-11-12	BU
Insider Sell: Personalis	21-10-15	MT
Personalis, Inc. Announces Board Changes	21-03-08	CI
Personalis, Inc. Announces Appointment of Susan Moriconi as VP of People and Chief Human Resources Officer	21-02-08	CI
Personalis, Inc. Appoints Kevin Dunne as New Head of Population Genomics	20-09-15	CI
Personalis, Inc. Appoints Stephen Moore as General Counsel	20-05-05	CI
Personalis, Inc. Elects Karin Eastham to the Board as Class III Director	19-09-12	CI

No results for this search